Ergoteles’s Phibro Animal Health PAHC Stock Holding History

Ergoteles’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,500	Closed	-$161K	–	1389
2023 Q1	$161K	Buy	+10,500	New	+$160K	0.01%	1047

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ergoteles's PAHC Position: Q2 2023 in Review

Ergoteles sold out of Phibro Animal Health (PAHC) in Q2 2023, closing a stake of 10,500 shares — an estimated $161K sold.

Ergoteles first reported a position in PAHC in Q1 2023 and held it in 1 quarter. The position peaked at $161K in Q1 2023. 131 funds tracked by Wall St. Rank hold PAHC as of Q2 2023.

Ergoteles reported no remaining Phibro Animal Health position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 10,500 Phibro Animal Health shares in Q2 2023, an estimated $161K.
Ergoteles first reported a position in Phibro Animal Health in Q1 2023 and held it in 1 quarter.
Ergoteles's Phibro Animal Health position peaked at $161K in Q1 2023.
131 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.